RAFAEL HOLDINGS, INC. Short-Term Debt
RAFAEL HOLDINGS, INC. (RFL) had Short-Term Debt of $21.90 million as of 2024-03-13, per its 10-Q filed 2026-06-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:DebtCurrent · last filed 2026-06-11
- 2024-03-13: Debt, Current $21.90M.
- 2023-03-21: Debt, Current $2.00M.
| Period end | Debt, Current |
|---|---|
| 2024-03-13 | $21.90M 10-Q · filed 2026-06-11 |
| 2023-03-21 | $2.00M 10-Q · filed 2024-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |